Immunotherapy with subcutaneous immunogenic autologous tumor lysate increases murine glioblastoma survival

Immunotherapeutic strategies for glioblastoma, the most frequent malignant primary brain tumor, aim to improve its disastrous consequences. On top of the standard treatment, one strategy uses T cell activation by autologous dendritic cells (DC) ex vivo loaded with tumor lysate to attack remaining ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Belmans, Jochen, Van Woensel, Matthias, Creyns, Brecht, Dejaegher, Joost, Bullens, Dominique M., Van Gool, Stefaan W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654749/
https://www.ncbi.nlm.nih.gov/pubmed/29066810
http://dx.doi.org/10.1038/s41598-017-12584-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654749/
https://www.ncbi.nlm.nih.gov/pubmed/29066810
http://dx.doi.org/10.1038/s41598-017-12584-0

Ejemplares similares